[分析简单的缩保留性植入物早期失效的危险因素]
Xu Zhang1, Zengxuan Wan1, Shibo Wei1
1Dept. of Stomatology, The Fourth Affiliated Hospital of Nanchang University, Nanchang 330009, China.
概括
吸烟和特定的植入物位置增加了早期失效的风险,对于简单的缩保留植入物. 了解这些风险因素,包括吸烟和安置在前下或后大,对于更好的患者结果至关重要.
科学领域:
- 牙科植入物学 牙科植入物学
- 在口腔外科手术.
- 生物材料科学 生物材料科学
背景情况:
- 牙科植入物的早期失败可能会导致患者的严重痛苦和治疗成本的增加.
- 通常使用的是简单的缩式保留植入物,但它们的长期成功取决于识别和减轻早期并发症的风险因素.
研究的目的:
- 为了识别与简单的缩保留植入物早期失败相关的患者,植入物和手术因素.
- 为优化手术前规划和手术执行提供基于证据的指导,以最大限度地减少植入物失败.
主要方法:
- 对于在2021年1月至2024年6月期间安置的3,533个简单的缩型保留植入物进行了回顾性分析.
- 包括患者的人口统计,病史,植入物特征和手术细节.
- 应用单变量和多变量统计分析来确定早期植入失败的风险因素.
主要成果:
- 在植入物水平上观察到的整体早期失败率为1.5%.
- 多变量分析确定吸烟 (OR=2.148),前下位置 (OR=3.669) 和后大位置 (OR=2.191) 是早期衰竭的重要风险因素.
- 在单变量分析中,同时提高上鼻底部的风险较高,但在多变量分析中没有显著意义.
结论:
- 应强烈建议患者戒烟接受简单的收式保留植入物.
- 在手术前的规划过程中,必须仔细考虑植入部位,特别是在前下和后大部.
- 这些发现有助于改进治疗策略,以提高简单的收型保留植入物的成功率.
相关概念视频
01:20Mismatch Repair
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
01:17Hypothesis: Accept or Fail to Reject?
The outcome of any hypothesis testing leads to rejecting or not rejecting the null hypothesis. This decision is taken based on the analysis of the data, an appropriate test statistic, an appropriate confidence level, the critical values, and P-values. However, when the evidence suggests that the null hypothesis cannot be rejected, is it right to say, 'Accept' the null hypothesis?
There are two ways to indicate that the null hypothesis is not rejected. 'Accept' the null hypothesis and 'fail to...
There are two ways to indicate that the null hypothesis is not rejected. 'Accept' the null hypothesis and 'fail to...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:14Prevention of Further Absorption of Poison
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...